UNSPSC 51422436: Hydrocortisone valerate

This classification denotes a therapeutic glucocorticoid with the molecular formula C26H38O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 68717P8FUZ, chemically known as 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione but more generally known as hydrocortisone valerate, which bears US NIH Compound Identifier 5754. European Medicines Agency schedules Hydrocortisone valerate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02570MIG.

UNSPSC 51422436 Hydrocortisone valerate is a Commodity code that theoretically classifies topical corticosteroid medications, but the recent state and local procurement activity tagged under it does not align with this scope. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the hydrocortisone valerate product category entirely. This mismatch suggests either a data-classification error in the opportunity posting or a misalignment between the code's nominal scope and how the jurisdiction tagged the procurement.

The Seminole County bid calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through a competitive bidding process, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023, and the contract structure includes an initial two-year term with a one-year renewal option. Vendors must provide unit costs, comply with drug-free workplace certification and E-Verify requirements, maintain specified insurance coverage, and meet potential FEMA-funded federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. The code shows minimal recent activity relevant to its stated pharmaceutical scope, warranting verification of coding accuracy before pursuing opportunities under this classification.